← All stocks

Runway Growth Finance Corp.

RWAY Net buying

CIK 0001653384 #3662 in the set updated 17 Sep 2026

Bought (120 mo)

$4.46B

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$163.85M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$163.85M

16 of 16 sales

Net

+$4.30B

+$4.30B against sales at will

By person

14 insiders · 241 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

OCM Growth Holdings LLC entity

10% owner

$4.40B (97)

$158.37M (11)

+$4.25B

7,029,668

16.77%

$46.18M

+41.3%

Carilion Clinic

10% owner

$24.40M (7)

—

+$24.40M

1,739,837

4.15%

$11.43M

+1,335%

Retirement Plan of Carilion Clinic

10% owner

$24.40M (7)

—

+$24.40M

1,739,837

4.15%

$11.43M

+1,335%

Carlson Capital, L.P. entity

10% owner

—

$3.69M (1)

−$3.69M

3,885,000

9.27%

$25.52M

−12.6%

SPRENG R DAVID

President and Co-CEO

$3.67M (43)

—

+$3.67M

429,321

1.02%

$2.82M

+150.0%

Raterman Thomas B.

CFO, COO

$2.98M (46)

—

+$2.98M

312,169

0.7449%

$2.05M

+178.8%

Brookfield Multi-Strategy Master Fund LP entity

Director

—

$1.79M (4)

−$1.79M

21,054,667

50.24%

$138.33M

−0.7%

Kovacs Gary

Director

$500.00K (8)

—

+$500.00K

34,797

0.0830%

$228.61K

+2,033%

Solimene Lewis

Director

$150.00K (6)

—

+$150.00K

10,439

0.0249%

$68.58K

+2,033%

Persily Julie

Director

$150.00K (7)

—

+$150.00K

10,439

0.0249%

$68.58K

+2,033%

GREIFELD ROBERT

Director

$119.10K (1)

—

+$119.10K

7,940

0.0189%

$52.17K

—

Engel John F.

Director

$100.02K (1)

—

+$100.02K

8,178

0.0195%

$53.73K

—

Thomson Carmela

CFO, Treasurer and Secretary

$55.74K (1)

—

+$55.74K

12,840

0.0306%

$84.36K

+165.3%

Rovner Michael

Co-Chief Executive Officer

$45.99K (1)

—

+$45.99K

7,000

0.0167%

$45.99K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 153

Amendments (4/A) skipped 4

Filings about a different issuer 0

Unreadable filings 0

Joint filings 47

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 16

Transactions with no price 0

Shares from compensation/vesting 186,046

History held since 19 Dec 2016